TRIM28 promotes the escape of gastric cancer cells from immune surveillance by increasing PD-L1 abundance
{{output}}
Immune checkpoint blockade (ICB) offers a new opportunity for treatment for gastric cancer (G.C.). Understanding the upstream regulation of immune checkpoints is crucial to further improve the efficacy of ICB therapy. Herein, using the CRISPR-Cas9-based genome... ...
